|
UBE2W expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.18830000000048E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.13119999999956E-05 |
| Normal-vs-Stage2 |
2.514800E-01 |
| Normal-vs-Stage3 |
8.922200E-03 |
| Normal-vs-Stage4 |
3.124600E-01 |
| Stage1-vs-Stage2 |
8.282100E-02 |
| Stage1-vs-Stage3 |
5.751000E-01 |
| Stage1-vs-Stage4 |
3.789400E-01 |
| Stage2-vs-Stage3 |
2.550400E-01 |
| Stage2-vs-Stage4 |
7.285200E-01 |
| Stage3-vs-Stage4 |
6.216400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.231930E-04 |
| Normal-vs-AfricanAmerican |
1.638800E-03 |
| Normal-vs-Asian |
2.135700E-02 |
| Caucasian-vs-AfricanAmerican |
9.515600E-01 |
| Caucasian-vs-Asian |
7.018400E-01 |
| AfricanAmerican-vs-Asian |
6.176600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80146999999575E-05 |
| Normal-vs-Female |
4.451700E-02 |
| Male-vs-Female |
3.081800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.742140E-03 |
| Normal-vs-Extreme_Weight |
3.53590000000681E-05 |
| Normal-vs-Obese |
4.244700E-03 |
| Normal-vs-Extreme_Obese |
1.264420E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.648000E-01 |
| Normal_Weight-vs-Obese |
6.150800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.149800E-01 |
| Extreme_Weight-vs-Obese |
2.744200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.899000E-01 |
| Obese-vs-Extreme_Obese |
6.607200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.775800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.135200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.31089999999101E-05 |
| Normal-vs-Age(81-100Yrs) |
2.523800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.665800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.818000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.343400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.124820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.486400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.770600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.603180E-04 |
| Normal-VS-Type2 PRCC |
3.612900E-04 |
| Normal-VS-KIRP CIMP |
6.770600E-01 |
| Normal-VS-Unclassified PRCC |
5.809500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.665400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.529200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.531400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.259980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.091600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.143000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88150999999026E-05 |
| Normal-vs-N1 |
3.774200E-01 |
| Normal-vs-N2 |
8.513400E-01 |
| N0-vs-N1 |
1.631830E-01 |
| N0-vs-N2 |
4.886800E-01 |
| N1-vs-N2 |
8.684200E-01 |
|
|
